These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26498874)

  • 1. Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
    Xu W; Jiang K; Shen M; Chen Y; Huang HY
    Oncol Rep; 2016 Jan; 35(1):352-8. PubMed ID: 26498874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
    Huang J; Sun C; Wang S; He Q; Li D
    Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
    Jiang K; Shen M; Chen Y; Xu W
    Oncol Rep; 2018 Aug; 40(2):943-951. PubMed ID: 29901178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR‑491‑5p.
    Li Y; Wang Y; Xie Z; Hu H
    Mol Med Rep; 2019 Apr; 19(4):2489-2496. PubMed ID: 30720092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JMJD2A predicts prognosis and regulates cell growth in human gastric cancer.
    Hu CE; Liu YC; Zhang HD; Huang GJ
    Biochem Biophys Res Commun; 2014 Jun; 449(1):1-7. PubMed ID: 24802408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A.
    Xu W; Jiang K; Shen M; Qian Y; Peng Y
    Biol Chem; 2015 Aug; 396(8):929-36. PubMed ID: 25719312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D.
    Zhang T; Hu Y; Ju J; Hou L; Li Z; Xiao D; Li Y; Yao J; Wang C; Zhang Y; Zhang L
    Sci Rep; 2016 Jan; 6():19346. PubMed ID: 26783084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
    BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
    Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
    Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
    Zhang X; Zhang X; Yu B; Hu R; Hao L
    Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
    Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S
    Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-137 and its target TGFA modulate cell growth and tumorigenesis of non-small cell lung cancer.
    Liu X; Chen L; Tian XD; Zhang T
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):511-517. PubMed ID: 28239819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
    Shi L; Zhang B; Sun X; Lu S; Liu Z; Liu Y; Li H; Wang L; Wang X; Zhao C
    Br J Cancer; 2014 Dec; 111(12):2316-27. PubMed ID: 25412236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous microRNA-424 predicts clinical outcome and its inhibition acts as cancer suppressor in human non-small cell lung cancer.
    Wang Y; Lv Z; Fu J; Wang Z; Fan Z; Lei T
    Biomed Pharmacother; 2017 May; 89():208-214. PubMed ID: 28231541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
    Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S
    Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
    Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.